US: AIHLF - Adcock Ingram Holdings Limited

Rentabilität für sechs Monate: 0%

Aktionsplan Adcock Ingram Holdings Limited


Über das Unternehmen

Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four divisions: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services.

weitere details
The company is involved in the sale of various healthcare, personal care, and homecare products through FMCG retailers and corporate pharmacies; OTC medicinal products through corporate and independent pharmacies; branded and generic prescription products, and specialized instrumentation and surgical products; and hospital products and services. It offers its products for allergies, antiretroviral, baby care, cardiovascular, cannabidiol, central nervous system, colds and flu, cough, dermatology, digestive well-being, energy, feminine hygiene, food and nutrition supplements, gastroenterology, generics, ophthalmology, pain, personal care, respiratory, vitamins, minerals supplements, and women's health. The company also provides critical care products, including intravenous solutions, blood collection products, and renal dialysis systems. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.

Industry Pharmaceuticals
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 172.18
Дивиденд ао 1.59
Сайт https://www.adcock.co.za
Цена ао 2.45
Preisänderung pro Tag: 0% (2.45)
Preisänderung pro Woche: 0% (2.45)
Preisänderung pro Monat: 0% (2.45)
Preisänderung über 3 Monate: 0% (2.45)
Preisänderung über sechs Monate: 0% (2.45)
Preisänderung pro Jahr: 0% (2.45)
Preisänderung über 3 Jahre: -21.97% (3.14)
Preisänderung über 5 Jahre: -43.16% (4.31)
Preisänderung über 10 Jahre: 0% (2.45)
Preisänderung seit Jahresbeginn: 0% (2.45)

Unterschätzung

Name Bedeutung Grad
P/S 0.7119 10
P/BV 0.0703 10
P/E 8.43 9
EV/EBITDA 7.25 9
Gesamt: 8.63

Effizienz

Name Bedeutung Grad
ROA, % 1.02 1
ROE, % 1.58 1
Gesamt: 1.67

Dividenden

Name Bedeutung Grad
Div yield, % 166.72 10
DSI 0.8571 8.57
Gesamt: 8.51

Pflicht

Name Bedeutung Grad
Debt/EBITDA 3.55 3
Gesamt: 5.8

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % -92.9 0
Rentabilität Ebitda, % -92.56 0
Rentabilität EPS, % 20.99 4
Gesamt: 0.8

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Andrew Gideon Hall CA (SA), BPharm CEO & Executive Director 1962 (63 Jahr)
Ms. Dorette Neethling CFO & Executive Director 1974 (51 Jahr)
Ms. Basadifeela Letsoalo Executive Director of Transformation & Human Capital and Executive Director 1963 (62 Jahr)
R. Essa Corporate Finance Director
Mr. Mahlatse Phalafala Company Secretary & Head of Legal
Mr. Nkosinathi Mthethwa Public Affairs Executive
Mr. Ashley Pearce Dip. Pharm, BCom Managing Director of Prescription
Mr. Colin Sheen B.Tech., M.B.A., NDip Mktg, PDBA Managing Director of Hospital
Mr. Tobie Krige MBA Managing Director of Distribution
Mr. Azhar Kaka Head of Sales - Consumer Division

Adresse: South Africa, Midrand, 1 New Road - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.adcock.co.za